We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

8411:TSEMizuho Financial Group, Inc. Analysis

Data as of 2026-06-13 - not real-time

NT$12.20

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Kingcan Holdings trades at TWD 12.20, just above its 20‑day SMA (12.08) but still under the 50‑day (12.19) and 200‑day (12.40) averages, indicating short‑term price pressure despite a broader bearish trend. Technical signals are mixed: the MACD histogram is positive and the MACD line sits above its signal, suggesting upside momentum, while RSI sits at a neutral 52.6 and volume is on an increasing trend.
Fundamentally, the company shows a robust 23.9% revenue growth and a forward PE of 21.8, yet margins remain thin (gross 6.9%, operating 2.6%) and earnings are just turning positive (forward EPS 0.56 vs trailing ‑0.69). Valuation metrics are compelling – price‑to‑book is 0.44, price‑to‑sales 0.27, and the DCF‑derived fair value (~TWD 93) signals a deep discount. The balance sheet carries a moderate debt load (debt‑to‑equity 54.7%) but cash flow is positive and the dividend payout is negligible, making the 0.41% yield appear sustainable. Market sentiment is at “Extreme Greed” (fear‑greed index 89.9), and the stock’s beta is ultra‑low (0.09), though 30‑day volatility is about 18%.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price hovering just above short‑term support with limited upside to resistance
  • Bullish MACD but overall bearish trend direction
  • Increasing volume supporting potential stability

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Strong revenue growth (24%) and turnaround to positive earnings
  • Significant valuation discount (P/B 0.44, DCF fair value ~TWD 93)
  • Low beta and improving cash flow offsetting moderate debt

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Deep valuation gap suggests long‑run upside potential
  • Sustained dividend albeit small, indicating cash generation capacity
  • Sector cyclicality and China‑centric exposure warrant a cautious but optimistic stance

Key Metrics & Analysis

Financial Health

Revenue Growth23.90%
Profit Margin0.23%
P/E Ratio21.8
ROE0.34%
ROA0.11%
Debt/Equity54.73
P/B Ratio0.4
Op. Cash FlowNT$419.0M
Free Cash FlowNT$632.0M

Technical Analysis

TrendBearish
RSI52.6
SupportNT$11.20
ResistanceNT$12.30
MA 20NT$12.08
MA 50NT$12.19
MA 200NT$12.40
MACDBullish
VolumeIncreasing
Fear & Greed Index89.86

Valuation

Fair ValueNT$93.10
GradeUndervalued
TypeBlend
Dividend Yield0.41%

Risk Assessment

Beta0.09
Volatility18.13%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.